These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11179604)

  • 41. New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo.
    Orosz A; Schrett J; Nagy J; Bartha L; Schön I; Nyéki O
    Int J Cancer; 1995 Jan; 60(1):82-7. PubMed ID: 7529212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
    Alonso R; Gnanadicom H; Fréchin N; Fournier M; Le Fur G; Soubrié P
    Eur J Neurosci; 1999 Mar; 11(3):967-74. PubMed ID: 10103090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitisation in mice.
    Costa FG; Frussa-Filho R; Felicio LF
    Eur J Pharmacol; 2001 Sep; 428(1):97-103. PubMed ID: 11779043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
    Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
    Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotensin induces mating in Saccharomyces cerevisiae cells that express human neurotensin receptor type 1 in place of the endogenous pheromone receptor.
    Leplatois P; Josse A; Guillemot M; Febvre M; Vita N; Ferrara P; Loison G
    Eur J Biochem; 2001 Sep; 268(18):4860-7. PubMed ID: 11559354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
    Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A
    Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
    Fridman R; Giaccone G; Kanemoto T; Martin GR; Gazdar AF; Mulshine JL
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6698-702. PubMed ID: 2168554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
    Beekman A; Helfrich B; Bunn PA; Heasley LE
    Cancer Res; 1998 Mar; 58(5):910-3. PubMed ID: 9500449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.
    Moody TW; Lee L; Ramos-Alvarez I; Jensen RT
    Eur J Pharmacol; 2019 Dec; 865():172735. PubMed ID: 31614143
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of the neurotensin NT(1) receptor in the developing rat brain following chronic treatment with the antagonist SR 48692.
    Lépée-Lorgeoux I; Betancur C; Souazé F; Rostène W; Bérod A; Pélaprat D
    J Neurosci Res; 2000 May; 60(3):362-9. PubMed ID: 10797539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
    Díaz-Cabiale Z; Fuxe K; Narváez JA; Finetti S; Antonelli T; Tanganelli S; Ferraro L
    Neuroreport; 2002 May; 13(6):763-6. PubMed ID: 11997683
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of receptor gene transcription is required to maintain cell sensitization after agonist exposure. Study on neurotensin receptor.
    Najimi M; Souazé F; Méndez M; Hermans E; Berbar T; Rostène W; Forgez P
    J Biol Chem; 1998 Aug; 273(34):21634-41. PubMed ID: 9705296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro functional evidence of different neurotensin-receptors modulating the motor response of human colonic muscle strips.
    Croci T; Aureggi G; Guagnini F; Manara L; Gully D; Fur GL; Maffrand JP; Mukenge S; Ferla G; Ferrara P; Chalon P; Vita N
    Br J Pharmacol; 1999 Aug; 127(8):1922-8. PubMed ID: 10482925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells.
    Moody TW; Zia F; Makheja A
    Peptides; 1993; 14(2):241-6. PubMed ID: 8387187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
    Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of neurotensin-stimulated mast cell secretion and carboxypeptidase A activity by the peptide inhibitor of carboxypeptidase A and neurotensin-receptor antagonist SR 48692.
    Miller LA; Cochrane DE; Feldberg RS; Carraway RE
    Int Arch Allergy Immunol; 1998 Jun; 116(2):147-53. PubMed ID: 9652308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells.
    Weiner RE; Avis I; Neumann RD; Mulshine JL
    J Cell Biochem Suppl; 1996; 24():276-87. PubMed ID: 8806110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurotensin excitation of serotonergic neurons in the rat nucleus raphe magnus: ionic and molecular mechanisms.
    Li AH; Yeh TH; Tan PP; Hwang HM; Wang HL
    Neuropharmacology; 2001 Jun; 40(8):1073-83. PubMed ID: 11406199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.